Please provide your email address to receive an email when new articles are posted on . Two phase 3 trials showed levofloxacin reduces the risk for multidrug-resistant TB after household exposure.
According to investigators, clinicians need to weigh the antimicrobial benefits of azithromycin, levofloxacin, and amoxicillin-based antibiotics against their potential cardiac risks in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback